AC Immune (ACIU) Operating Leases (2017 - 2025)

AC Immune (ACIU) has 8 years of Operating Leases data on file, last reported at $4.6 million in Q4 2025.

• Quarterly Operating Leases fell 8.13% year-over-year to $4.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.6 million (down 8.13% YoY) and the FY2025 annual result came in at $4.4 million, down 11.43% from the prior year.
• Operating Leases advanced to $4.6 million in Q4 2025 per ACIU's latest filing, from $4.5 million in the prior quarter.
• Across five years, Operating Leases topped out at $3.2 billion in Q4 2023 and bottomed at $2.0 million in Q3 2022.
• The 5-year median for Operating Leases is $3.8 million (2024), against an average of $607.9 million.
• The widest annual swing landed in 2021, when Operating Leases surged 140132.61%; it then slumped 99.91% in 2022.
• Tracing ACIU's Operating Leases over 5 years: stood at $2.5 billion in 2021, then sank by 99.91% to $2.3 million in 2022, then soared by 136079.34% to $3.2 billion in 2023, then plunged by 99.84% to $5.0 million in 2024, then declined by 8.13% to $4.6 million in 2025.
• Per Business Quant, the three latest ACIU Operating Leases figures stand at $4.6 million (Q4 2025), $4.5 million (Q3 2025), and $4.7 million (Q2 2025).

Peer Comparison